EH
Immunservice Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Inhaled IL-2 | Lung Metastases | Pre-clinical (based on prior clinical experience) |
| Intravesical IL-2 | Bladder Cancer | Pre-clinical |
| Local IL-2 Injection | Virus-Induced Tumors | Pre-clinical |
| IL-2 Immunotherapy | Obesity | Research |
| IL-2 Adjuvant | Veterinary Vaccine Booster | Research |